多原子分析揭示了BCAT1在mTOR激活中由B细胞受体和TLR9发挥的关键作用
Rui Guo1,2,3, Yizhe Sun1,2,3, Matthew Y Lim4,5
1Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
The Journal of clinical investigation
|September 9, 2025
概括
这项研究揭示了B淋巴细胞如何利用新陈代谢来激活和分化. 抑制BCAT1,一个关键的酶,有效地准B细胞驱动的癌症和自身免疫性疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 代谢研究研究 代谢研究
背景情况:
- 乙淋巴细胞对适应性免疫非常重要,产生抗体并影响T细胞的反应.
- 了解支持B细胞激活和分化的免疫代谢至关重要,特别是在对各种刺激的反应中.
- 不同的受体信号可以导致不同的B细胞功能和疾病状态.
研究的目的:
- 系统地研究人类B细胞对各种受体刺激的代谢反应.
- 阐明免疫代谢在B细胞激活和分化中的作用.
- 在B细胞介导疾病中识别潜在的治疗点.
主要方法:
- 对人类B细胞的转录,转化和代谢特征进行系统分析.
- 使用B细胞受体 (BCR),TLR9,CD40-连接体 (CD40L),IL-4及其组合刺激B细胞.
- 研究分支链氨基酸转胺酶1 (BCAT1) 的功能及其抑制.
主要成果:
- 独立于T细胞的BCR/TLR9共刺激显著诱导了BCAT1,局限于溶酶体膜.
- BCAT1支持分支链氨基酸合成和mTORC1在B细胞中的激活.
- 抑制BCAT1抑制了BCR/TLR9刺激的B细胞增殖,IL-10产生和淋巴瘤生长,但没有抑制CD40L/IL-4反应.
结论:
- 受体刺激重塑免疫代谢以支持特定的B细胞表型.
- BCAT1是一种关键的代谢酶,由激活B细胞中的BCR/TLR9信号诱导.
- BCAT1代表了对B细胞恶性瘤和自身免疫性疾病的有前途的治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
B Cell Activation and Differentiation
15.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.7K
The JAK-STAT Signaling Pathway
11.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.7K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K


